查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024641

家庭靜脈輸液治療市場報告：按產品、應用和地區分類（2026-2034 年）

Home Infusion Therapy Market Report by Product, Application, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球家庭輸液治療市場規模達477億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到728億美元，2026年至2034年的複合年成長率為4.65%。老年人口的成長以及對居家醫療需求的不斷成長，正在推動市場成長。

家庭靜脈輸液治療市場的發展趨勢：

先進靜脈輸液治療技術的廣泛應用

技術進步正在提升家庭輸液治療水平，智慧輸液幫浦和安全軟體的引入提高了輸液的準確性、安全性和效率。這些創新也減少了用藥錯誤，增強了監測能力，並實現了與數位系統的無縫整合，從而簡化了患者的居家照護，減輕了看護者的負擔。例如，2024年4月，百特公司（Baxter）的Novum IQ大容量輸液幫浦和Dose IQ安全軟體獲得FDA核准，透過提供整合的智慧型幫浦解決方案，進一步提升了居家輸液治療水準。這項進步提高了病患的安全性和治療效率，緩解了醫護人員的工作壓力，並促進了互聯醫療的發展。

對專業靜脈輸液服務的需求不斷成長

隨著越來越多的慢性病患者需要複雜的治療方案，對專業靜脈輸液服務的需求也日益成長。此外，這些服務透過在家中提供個人化治療，減少了患者就醫的次數。這種個人化的治療方式有助於有效管理長期疾病，同時提升患者的舒適度和治療效果。例如，Dynamic Access於2024年2月推出了Dynamic Infusion，這是一家專門為患有自體免疫疾病和多發性硬化症等慢性病的患者提供家庭靜脈輸液護理服務的專業機構。他們也與35多家專業藥局合作，每年在九個州進行超過1萬次家庭訪視，提升患者照護。

數位健康工具的整合

將數位化工具整合到居家輸液治療中，能夠改善病患監測，並實現醫護人員與病患之間的即時數據共用。此外，這些系統透過提供治療進展訊息，增強了遠距醫療管理，從而提高了患者的用藥依從性，便於調整治療方案，並最大限度地減少了面對面諮詢的需求。例如，2024年5月，Moog公司專為家庭輸液治療設計的CURLIN 8000攜帶式輸液系統獲得了FDA的核准。該系統能夠提供精準的多藥輸注和直覺的使用者介面，並且與CURLIN RxManager配合使用，能夠提高居家照護藥劑師和患者的安全性和易用性。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球家庭靜脈輸液治療市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 點滴幫浦
    • 主要部分
      • 彈性體
      • 電子機械
      • 重力型
      • 其他
  • 靜脈輸液裝置
  • 靜脈套管
  • 無針頭連接器

第7章 市場區隔：依應用領域分類

  • 抗感染藥物
  • 內分泌學
    • 主要部分
      • 糖尿病
      • 其他
  • 水療法
    • 主要部分
      • 運動員
      • 其他
  • 化療
  • 經腸營養
  • 腸外營養
  • 特種藥品
  • 其他

第8章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章 SWOT 分析

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Eli Lilly and Company
    • Fresenius SE & Co. KGaA
    • ICU Medical Inc.
    • JMS Co. Ltd.
    • Nipro Corporation
    • Option Care Health Inc.（Walgreen Co.）
    • Smiths Group plc
    • Terumo Corporation
Product Code: SR112026A4098

The global home infusion therapy market size reached USD 47.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 72.8 Billion by 2034, exhibiting a growth rate (CAGR) of 4.65% during 2026-2034. The growing elderly population, along with the increasing preference for home healthcare, is propelling the market.

HOME INFUSION THERAPY MARKET ANALYSIS:

  • Major Market Drivers: Rising advancements in medical technology are making at-home infusions safer and more efficient, which is propelling the market.
  • Key Market Trends: The increasing number of chronic disease cases is advancing the need for cost-effective home treatments, thereby acting as a significant growth-inducing factor.
  • Competitive Landscape: Some of the major market companies include B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Eli Lilly and Company, Fresenius SE & Co. KGaA, ICU Medical Inc., JMS Co. Ltd., Nipro Corporation, Option Care Health Inc. (Walgreen Co.), Smiths Group plc, and Terumo Corporation, among many others.
  • Geographical Trends: North America exhibits a clear dominance in the market due to strong reimbursement systems and increasing prevalence of chronic diseases, thereby fostering higher demand for convenient at-home treatment solutions across the region.
  • Challenges and Opportunities: Inconsistent patient safety and the need for proper administration are hindering the market. However, enhancing training for caregivers and integrating advanced monitoring technologies for real-time oversight of infusion treatments will continue to strengthen the market over the forecast period.

HOME INFUSION THERAPY MARKET TRENDS:

Increasing Adoption of Advanced Infusion Technology

Technological advancements are enhancing home infusion therapy by introducing smart infusion pumps and safety software that improve precision, safety, and efficiency. In contrast, these innovations help to reduce medication errors, offer better monitoring, and provide seamless integration with digital systems, thereby streamlining home-based care for patients and reducing the burden on caregivers. For instance, in April 2024, Baxter received U.S. FDA clearance for its Novum IQ large volume infusion pump and Dose IQ Safety Software, thereby enhancing home infusion therapy by offering integrated smart pump solutions. This development boosts patient safety and efficiency, addressing clinician workload challenges and advancing connected care.

Growing Demand for Specialized Infusion Services

The need for specialized infusion services has grown as more patients require complex treatments for chronic conditions. In addition, these services provide tailored therapies delivered in a home setting, thereby reducing the need for hospital visits. Furthermore, this personalized approach helps to manage long-term illnesses effectively while improving patient comfort and treatment outcomes. For instance, in February 2024, Dynamic Access launched dynamic infusion, a specialty home infusion nursing provider, which is serving patients with chronic conditions like autoimmune disorders and multiple sclerosis. Also, they partnered with 35+ specialty pharmacies, offering over 10,000 home visits annually across nine states, enhancing patient care.

Integration of Digital Health Tools

The integration of digital tools in home infusion therapy is enabling better patient monitoring and real-time data sharing between healthcare providers and patients. Moreover, these systems enhance remote care management by offering insights into therapy progress, thereby improving adherence and facilitating adjustments to treatment plans while minimizing the need for in-person consultations. For instance, in May 2024, Moog received U.S. FDA clearance for the CURLIN 8000 ambulatory infusion system, designed specifically for home infusion therapy. This system offers precise multi-therapy infusions and intuitive user interfaces and integrates with CURLIN RxManager, enhancing safety and control for home care pharmacists and patients.

GLOBAL HOME INFUSION THERAPY INDUSTRY SEGMENTATION:

Breakup by Product:

  • Infusion Pumps
    • Elastomeric
    • Electromechanical
    • Gravity
    • Others
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors

In fusion pumps currently hold the largest home infusion therapy market demand

Infusion pumps exhibit a clear dominance in the market due to their precision in medication delivery, as they offer defined medication delivery and enhancing patient care. For example, Baxter launched its advanced Spectrum IQ pump, thereby improving patient safety and remote monitoring capabilities for home-based care.

Breakup by Application:

  • Anti-Infective
  • Endocrinology
    • Diabetes
    • Others
  • Hydration Therapy
    • Athletes
    • Others
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals

Anti-infectives currently hold the largest home infusion therapy market statistics

Anti-infectives lead the market due to their increased use in treating severe infections, such as pneumonia, with intravenous antibiotics. For instance, Smiths Medical's CADD infusion system facilitates precise delivery and supports increased adoption.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America currently dominates the infusion therapy market revenue

The home infusion therapy market outlook has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

As per the home infusion therapy market overview, North America dominates the market, which is driven by advanced healthcare infrastructure and increasing demand for home-based treatments. Moreover, the region benefits from a growing elderly population and rising chronic disease cases, prompting more home infusion therapies. For example, CVS Health expanded its home infusion services, thereby enhancing access to these treatments across the U.S. Furthermore, high demand for at-home care, alongside supportive reimbursement policies and technological advancements, further strengthens the region's dominance in this market.

COMPETITIVE LANDSCAPE:

The home infusion therapy market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all market home infusion therapy companies have also been provided. Some of the key players in the market include:

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Eli Lilly and Company
  • Fresenius SE & Co. KGaA
  • ICU Medical Inc.
  • JMS Co. Ltd.
  • Nipro Corporation
  • Option Care Health Inc. (Walgreen Co.)
  • Smiths Group plc
  • Terumo Corporation

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global home infusion therapy market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global home infusion therapy market?
  • What is the impact of each driver, restraint, and opportunity on the global home infusion therapy market growth?
  • What are the key regional markets?
  • Which countries represent the most attractive home infusion therapy market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the home infusion therapy market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the home infusion therapy market?
  • What is the competitive structure of the global home infusion therapy market?
  • Who are the key players/companies in the global home infusion therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Home Infusion Therapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Infusion Pumps
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Elastomeric
      • 6.1.2.2 Electromechanical
      • 6.1.2.3 Gravity
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Intravenous Sets
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 IV Cannulas
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Needleless Connectors
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Anti-Infective
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Endocrinology
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Diabetes
      • 7.2.2.2 Others
    • 7.2.3 Market Forecast
  • 7.3 Hydration Therapy
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Athletes
      • 7.3.2.2 Others
    • 7.3.3 Market Forecast
  • 7.4 Chemotherapy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Enteral Nutrition
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Parenteral Nutrition
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Specialty Pharmaceuticals
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 B. Braun Melsungen AG
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Baxter International Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Becton Dickinson and Company
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Eli Lilly and Company
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Fresenius SE & Co. KGaA
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 ICU Medical Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 JMS Co. Ltd.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
    • 13.3.8 Nipro Corporation
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Option Care Health Inc. (Walgreen Co.)
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Smiths Group plc
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Terumo Corporation
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Home Infusion Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Home Infusion Therapy Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Home Infusion Therapy Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Home Infusion Therapy Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Home Infusion Therapy Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Home Infusion Therapy Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Home Infusion Therapy (Infusion Pumps) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Home Infusion Therapy (Infusion Pumps) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Home Infusion Therapy (Intravenous Sets) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Home Infusion Therapy (Intravenous Sets) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Home Infusion Therapy (IV Cannulas) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Home Infusion Therapy (IV Cannulas) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Home Infusion Therapy (Needleless Connectors) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Home Infusion Therapy (Needleless Connectors) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Home Infusion Therapy (Anti-Infective) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Home Infusion Therapy (Anti-Infective) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Home Infusion Therapy (Endocrinology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Home Infusion Therapy (Endocrinology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Home Infusion Therapy (Hydration Therapy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Home Infusion Therapy (Hydration Therapy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Home Infusion Therapy (Chemotherapy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Home Infusion Therapy (Chemotherapy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Home Infusion Therapy (Enteral Nutrition) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Home Infusion Therapy (Enteral Nutrition) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Home Infusion Therapy (Parenteral Nutrition) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Home Infusion Therapy (Parenteral Nutrition) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Home Infusion Therapy (Specialty Pharmaceuticals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Home Infusion Therapy (Specialty Pharmaceuticals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Home Infusion Therapy (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Home Infusion Therapy (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: North America: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: North America: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: United States: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: United States: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Canada: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Canada: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Asia-Pacific: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Asia-Pacific: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: China: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: China: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Japan: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Japan: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: India: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: India: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: South Korea: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: South Korea: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Australia: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Australia: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Indonesia: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Indonesia: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Others: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Others: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Europe: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Europe: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Germany: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Germany: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: France: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: France: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: United Kingdom: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: United Kingdom: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Italy: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Italy: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Spain: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Spain: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Russia: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Russia: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Latin America: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Latin America: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Brazil: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Brazil: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Mexico: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Mexico: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Others: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Others: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Middle East and Africa: Home Infusion Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Middle East and Africa: Home Infusion Therapy Market: Breakup by Country (in %), 2025
  • Figure 79: Middle East and Africa: Home Infusion Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Global: Home Infusion Therapy Industry: SWOT Analysis
  • Figure 81: Global: Home Infusion Therapy Industry: Value Chain Analysis
  • Figure 82: Global: Home Infusion Therapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Home Infusion Therapy Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Home Infusion Therapy Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Home Infusion Therapy Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Home Infusion Therapy Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Home Infusion Therapy Market: Competitive Structure
  • Table 6: Global: Home Infusion Therapy Market: Key Players